SynCardia Total Artificial Heart Patient With End-Stage Renal Failure Recovers Kidney Function After Two Months Of Support
For almost two months after the implant surgery, Gonzalez continued to produce no urine, so she was scheduled for surgery on Jan. 2 to receive a permanent catheter. However, on Jan. 1, she began making urine.
"Even I had started to lose hope," said Dr. Morales. "And now, she has normal function to her kidney. This experience has made me very optimistic that many of the livers and kidneys that fail due to heart disease could actually be recoverable with the total artificial heart. Every time we put in this device, we learn something new."
On Jan. 12, Cincinnati Children's received approval from the FDA to switch Gonzalez to the Freedom® portable driver, the world's first wearable power supply for the SynCardia Total Artificial Heart. The Freedom driver will allow Gonzalez, who feels healthier than she has in years, to leave the hospital and return home for the first time since October.
"I keep telling her that I don't know what God's plan is, but there is a plan," said Gonzalez's mother, Leslie Hudson. "And she just has to keep pushing through."The Freedom driver is CE approved for use in Europe and undergoing an FDA-approved Investigational Device Exemption (IDE) clinical study in the U.S. Read the feature story on Gonzalez published in the Cincinnati Enquirer at http://news.cincinnati.com/article/20130217/NEWS/302130225/Children-s-patient-pioneer-artificial-heart?nclick_check=1 CAUTION – The Freedom portable driver is an investigational device, limited by United States law to investigational use. About the SynCardia temporary Total Artificial Heart SynCardia Systems, Inc. ( Tucson, AZ) is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. Originally used as a permanent replacement heart, the SynCardia Total Artificial Heart is currently approved as a bridge to transplant for people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure). There have been more than 1,100 implants of the Total Artificial Heart, accounting for more than 300 patient years of life. Similar to a heart transplant, the SynCardia Total Artificial Heart replaces both failing heart ventricles and the four heart valves, eliminating the symptoms and source of end-stage biventricular failure. Unlike a donor heart, the Total Artificial Heart is immediately available at SynCardia Certified Centers. It is the only device that provides immediate, safe blood flow of up to 9.5 liters per minute through each ventricle. This high volume of safe blood flow helps speed the recovery of vital organs, helping make the patient a better transplant candidate. Forbes Ranks SynCardia #69 Among "America's Most Promising Companies" In its February 2013 issue, Forbes selected SynCardia as one of "America's Most Promising Companies" for the second consecutive year. On the list of 100 privately held, high-growth companies with bright futures, SynCardia was selected #69, moving up eight spots from its #77 ranking last year. See the full list of SynCardia Awards & Recognition here. For additional information, please visit: http://www.syncardia.comLike SynCardia on Facebook - http://www.facebook.com/pages/SynCardia-Systems-Inc/191245900926019 Follow SynCardia on Twitter – http://twitter.com/SynCardia Connect with SynCardia on LinkedIn - http://www.linkedin.com/company/syncardia-systems-inc.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV